Evidence map›Paper›PMID 42148331›Full record

ArticlePostepy dermatologii i alergologii2026

Hexa classification of erythemato-squamous disease using deep dual features-based neural network.

Latha Subramani, Sumathi Selvaraju

Abstract read
In one paragraph

Article in Postepy dermatologii i alergologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Latha SubramaniDepartment of Information Technology, Mahendra Engineering College (Autonomous), Mahendhirapuri, Namakkal, India.
Sumathi SelvarajuDepartment of Electrical and Electronics Engineering, Mahendra Engineering College (Autonomous), Mahendhirapuri, Namakkal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Erythemato-squamous disease (ESD) is a skin disorder characterized by both erythema and squamous changes. These conditions often involve inflammation and can manifest with various symptoms, such as itching, burning, and discomfort. However, distinguishing between different conditions solely based on external symptoms may be challenging and lead to misdiagnosis. Aim: To overcome these issues, this work proposes a novel deep learning-based Hexa-ESD framework to efficiently classify clinical skin images into hexa skin diseases. Material and methods: Initially, the clinical skin images are gathered from openly available datasets. The self-prepared clinical skin images are denoised by the Contrast stretching Adaptive Histogram Equalization (CSAHE) technique for eliminating the noise artifacts. These noise-free images are augmented with standard transformation techniques like scaling, flipping, and zooming to enhance the training dataset. The deep learning-DuoNet, which is a hybridization of DarkNet and ShuffleNet, is applied to retrieve the spatial features from the noise-free images. Then, the extracted features are fed into the walrus optimization (WalO) algorithm by dealing with complex non-linear problems for selecting the best features. These selected features are fused for classification using deep belief network (DBN) to detect the hexa ESD cases namely chronic dermatitis, lichen planus, seborrheic dermatitis, pityriasis rosea, psoriasis, and pityriasis rubra pilaris. Results: The proposed Hexa-ESD model yields an accuracy rate of 97.69% for the classification of ESD cases. From the evaluation, the Hexa-ESD framework increases the overall accuracy by 3.26%, 1.93% and 18.21% for ReliefF algorithm, Extreme Gradient Boosting and EPFS algorithm, respectively. Conclusions: The proposed Hexa-ESD framework provides an effective solution for multi-class classification of ESD using clinical skin images and reliable as a computer-aided diagnostic tool for dermatological applications.

Indexed as

DarkNetdeep learningerythemato-squamous diseaseShuffleNetwalrus optimization algorithm

Identifiers

PMID42148331
PMCPMC13178241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.